Close menu




April 6th, 2021 | 07:30 CEST

Xiaomi, Pollux Properties, Deutsche Telekom - Strong development!

  • Investments
Photo credits: pixabay.com

Delayed vaccination programs, hard lockdown, empty city centers - The DAX has become immune to the uncertain outlook and chaotic crisis management in Germany. At 15,000 points, a new all-time high was climbed last week. The stock market lights continue to be green, both in terms of the chart and fundamentals. The reason for this is the positive developments in the United States. The vaccination marathon, where every adult US citizen is to receive a vaccination offer by the end of May, is to be followed by a gigantic economic stimulus program to revive the economy. These developments should boost the leading stock exchanges on Wall Street and carry the European markets along with them.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: KYG9830T1067 , SG1I77884290 , US2515661054

Table of contents:


    Deutsche Telekom - Potential through subsidiary

    Good figures, a strong outlook and an exceptionally well-performing subsidiary from America. These were the results of Deutsche Telekom's Annual General Meeting last Thursday. According to CEO Höttges, the Group made good progress through the year. Revenue climbed 25.4% to more than EUR 100 billion, while adjusted EBITDA rose 41.6% to EUR 35 billion. Only the dividend payment, which remains at a mere EUR 0.60 despite the increased earnings, drew quiet criticism from shareholders.

    Among other things, the US subsidiary T-Mobile US, in which Deutsche Telekom currently holds a 44% stake, was responsible for the leap in revenue into the triple digits. However, a voting rights agreement allows the US Company to be consolidated in the balance sheet. There is also a call option valid until July 2024, under which the Bonn-based Company can acquire 101 million T-Mobile shares from SoftBank. However, according to the CEO, there is no rush here, as Deutsche Telekom can buy at a lower price than the current share price. The T-Share has finally awoken from its slumber. The high of EUR 17.91 reached in 2017 is within reach. The Deutsche Telekom story is still on track!

    Pollux Properties - Undervalued Asian pearl

    Germany is not the only country suffering from the consequences of the Corona pandemic. Even Singapore, the wealthy city-state with the highest standard of living in the Southeast Asian region, has seen its growth dip. After years of economic growth averaging 13%, there was a slump of an estimated 6% in the Corona year 2020. Significantly hit by the lockdowns and the shift to home offices was the office real estate sector. Here, rental prices shrank by almost 11%, and a further 5% drop in prices is expected in 2021 due to the change in working conditions. Yields on the Singapore stock exchange were also below most Asian trading centers on average. Here, however, analysts expect outperformance and a continuation of economic growth at pre-crisis levels.

    Despite the lull in the commercial real estate market, the full year 2020 went more than satisfactorily for property manager Pollux Properties. The reason was the diversification of the business model on three pillars. Although the real estate development segment came to a standstill in 2020, the Company maintained its revenue at around the previous year's level despite Corona through its portfolio properties. Pollux manages properties in Singapore with an equivalent value of around EUR 200 million with an extensive portfolio of residential properties and office and retail space - and its third pillar, fund management. Although there was no dividend for investors this year, after the Corona Crisis year and the boom expected again in subsequent years, the Company plans to increase distributions constantly.

    With a well-filled cash position of EUR 19.74 million, the portfolio of existing properties will also be increased further. However, the most significant growth driver is likely to be fund management. This area is currently still at the beginning of its development. Looking at the valuation of Pollux Properties, one can see a serious undervaluation. Total assets of just under EUR 236 million are offset by liabilities of only EUR 112 million. Thus, the net assets per share of EUR 0.045 are 60% above the current stock market price of EUR 0.021. In addition to the home stock exchange in Singapore, the share is also traded in Frankfurt.

    Xiaomi - Positive signs

    A great honor for the technology Company Xiaomi. According to Counterpoint Research, the Chinese Company is the new No. 1 smartphone maker in China and No. 3 globally, with a global market share of 13% in February. Huawei ranks No. 4 in China with a global market share of 4%. Samsung, the world's No. 1 handset maker, had a 20% market share, while Apple ranked No. 2 with a 17% market share and Huawei fell to No. 6 globally.

    Xiaomi also continues to get serious in the electric car sector. After several denials, Company leader Lei Jun has announced that the Company will enter the production of electric cars. Xiaomi plans to invest a total of USD 10 billion from its approximately USD 16 billion cash reserves to build a vehicle that will compete with domestic electric carmakers such as Nio or BYD and the top dog Tesla. In terms of the chart, the correction for the Xiaomi share could be over. The chart is forming a bottom in the USD 14.50 area. After a successful test, there would be a short-term potential of up to USD 19.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read